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Abstract
Introduction: We aimed at dissociating the neural correlates of memory disorders in Alzheimer’s disease (AD) and
frontotemporal lobar degeneration (FTLD).
Methods: We included patients with AD (n=19, 11 female, mean age 61 years) and FTLD (n=11, 5 female, mean age 61
years) in early stages of their diseases. Memory performance was assessed by means of verbal and visual memory subtests
from the Wechsler Memory Scale (WMS-R), including forgetting rates. Brain glucose utilization was measured by
[18F]fluorodeoxyglucose positron emission tomography (FDG-PET) and brain atrophy by voxel-based morphometry (VBM)
of T1-weighted magnetic resonance imaging (MRI) scans. Using a whole brain approach, correlations between test
performance and imaging data were computed separately in each dementia group, including a group of control subjects
(n=13, 6 female, mean age 54 years) in both analyses. The three groups did not differ with respect to education and
gender.
Results: Patients in both dementia groups generally performed worse than controls, but AD and FTLD patients did not differ
from each other in any of the test parameters. However, memory performance was associated with different brain regions in
the patient groups, with respect to both hypometabolism and atrophy: Whereas in AD patients test performance was
mainly correlated with changes in the parieto-mesial cortex, performance in FTLD patients was correlated with changes in
frontal cortical as well as subcortical regions. There were practically no overlapping regions associated with memory
disorders in AD and FTLD as revealed by a conjunction analysis.
Conclusion: Memory test performance may not distinguish between both dementia syndromes. In clinical practice, this may
lead to misdiagnosis of FTLD patients with poor memory performance. Nevertheless, memory problems are associated with
almost completely different neural correlates in both dementia syndromes. Obviously, memory functions are carried out by
distributed networks which break down in brain degeneration.
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Introduction
Memory problems are the most frequent complaint by patients
presenting for clinical assessment when dementia is suspected.
Although disorders of memory have been defined as a necessary
criterion in the diagnosis of dementing illness (ICD-10; DSM-III),
these definitions have largely been based on the most frequent
dementia syndrome - Alzheimer’s disease (AD). Memory impair-
ments have been claimed to play a subordinate role in other forms
of neurodegenerative disorders, such as frontotemporal lobar
degeneration (FTLD). Here, memory has been assumed to remain
largely intact at least in early stages of the disease [1,2] in contrast
to other cognitive domains such as behavioral abnormalities,
executive and language deficits, depending on the subtype [3–5].
The finding that AD patients face more problems in anterograde
episodic memory than FTLD patients has been confirmed in
several studies [6–13], although there is accumulating evidence
that memory can be remarkably impaired even in early stages of
FTLD [14–17]. One explanation of this latter finding is that
temporo-mesial/hippocampal atrophy is also found in FTLD,
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Accordingly, it has been claimed that FTLD cannot be clearly
distinguished from AD on the basis of memory test performance
[23–27], at least not on the individual level relevant for diagnostic
classification [28]. Additionally, methodological issues such as
differences in lesion patterns, verification of diagnosis, different test
measures etc. further complicate the comparison of studies
[29,30]. With respect to the nature of their memory problems,
FTLD patients were supposed to show more ‘frontal’ deficits such
as problems in organizing material that is to be learned
[8,11,29,31] or in retrieving information rather than storing it
[11,12,24,29]. By contrast, AD patients have been claimed to
exhibit stronger consolidation problems as they seem to lose more
information over time [11,24]. Other studies have shown stronger
visual memory problems in AD patients probably due to
additional visuo-spatial problems which cannot be compensated
for by verbal memory strategies [14,18].
Furthermore, a number of studies have related memory
performance in dementia patients directly to the lesion patterns
as revealed by imaging techniques -such as Magnetic Resonance
Imaging (MRI) and [18F] FluoroDeoxyGlucose Positron Emission
Tomography (FDG-PET)- in order to explain variability across
studies. AD leads to atrophy and/or hypometabolism in temporo-
mesial [32–35] as well as parieto-mesial areas [35–39] as early
signs of the disease. Accordingly, several studies (e.g. [40,41]) have
shown that in patients with amnestic mild cognitive impairment
(aMCI), a prestage of AD, deficits in word list encoding and
retrieval correlate with hippocampal atrophy as well as with
hippocampal and parieto-medial hypometabolism (precuneus,
posterior cingulate). Correlations of memory deficits and hippo-
campal atrophy in AD have been confirmed in several studies [42–
44]. Using Single-photon Emission Computed Tomography
(SPECT), Caroli and colleagues [45] found that hypoperfusion
in the retrosplenial cortex and precuneus was associated with
memory impairment, but that only hippocampal hypoperfusion
predicted a conversion of MCI to AD. Desgranges and colleagues
[46,47] found correlations between lower performance in verbal
memory (word list, story recall) and PET hypometabolism in the
temporo-medial cortex, thalamus, cingulate and parieto-medial
areas, but also in lateral temporal, parietal and frontal cortices in
AD patients (see also ref [39]). Furthermore, it has been shown
that hippocampal hypometabolism affects the recall of (at least
recent) episodes from autobiographical memory in AD [48].
By contrast, there are only very few studies investigating the
relationship between hypometabolism and/or atrophy and mem-
ory functions in patients with FTLD. In semantic dementia,
hypometabolism and atrophy are found especially in left lateral
temporal areas [20,22,49,50], but also in the hippocampus [50,51]
suggesting that memory is more severely affected than previously
assumed (see above). As shown in a further study [52], frontal-
variant FTLD patients (‘frontotemporal dementia’ according to
[1]) had difficulties in retrieving autobiographical memories
compared to control subjects (see also [17]). These difficulties
were related to orbitofrontal as well as temporal hypometabolism.
To our knowledge, there is only one recent study [53] in which
memory performance in AD and FTLD has been linked to brain
atrophy. Using atrophy ratings, the authors found that neural
correlates differed (temporal and frontal areas in AD vs. frontal in
FTLD), although memory performance was alike between both
dementia groups. However, no previous study has systematically
explored the neural correlates of memory in early AD and FTLD
patients with respect to both regional hypometabolism as
measured with [18F]fluorodeoxyglucose positron emission tomog-
raphy (FDG-PET) as well as brain atrophy as measured with
voxel-based morphometry (VBM) of magnetic resonance imaging
(MRI) in a whole brain approach. This was the aim of the present
study.
Based on the studies outlined above, we drew the following
hypotheses: General lesion patterns as revealed by hypometabo-
lism and atrophy should differ between the two syndromes, with
a parietotemporal distribution in AD and frontotemporal in FTLD
[22]. With respect to memory performance, previous studies did
not allow to clearly predict group differences in encoding or
retrieving information, but probably with respect to forgetting
rates as some studies found a greater loss of information over time
in AD [11,24]. Nevertheless, we expected the neural correlates of
memory to differ between the groups according to the differences
in lesion patterns [53], which include memory relevant areas in
both diseases.
Materials and Methods
Subjects
Subjects were recruited from the Day Clinic of Cognitive
Neurology at the University of Leipzig. Our study included 19
patients with an early stage of probable AD and 11 patients with
an early stage of FTLD (frontotemporal dementia (FTD) n=4,
semantic dementia (SD) n=5, mixed type n=2). Probable AD
was diagnosed according to NINCDS-ADRDA (National Institute
of Neurological and Communicative Disorders and Stroke-
Alzheimer’s Disease and Related Disorders Association) criteria
[54]. All AD subjects also fulfilled the revised NINCDS-ADRDA
criteria [55]. Diagnosis of FTLD was based on the criteria of ref
[1]. Symptom severity was measured with the Clinical Dementia
Rating Scale (CDR) [56].
We included 13 controls who presented at the clinic because of
subjective cognitive complaints, which were not objectively
confirmed by a comprehensive neuropsychological and clinical
Table 1. Subject characteristics and test results for each
group.
Controls AD FTLD GLM (F/p)
n1 3 1 9 1 1
Gender (m/f) 7/6 8/11 6/5 x
2=.62/p=.73
Age (ys) 53.92 (6.00) 60.89 (6.94) 61.27 (6.53) 5.3/.009
Education (ys) 12.31 (3.14) 10.95 (3.1) 11.64 (3.88) .7/.526
CDR (score) .23 (.26) .71 (.25) .73 (.26) 16.2/,.001
WMS-LM1 28.62 (4.82) 11.47 (6.75) 13.10 (6.06) 24.4/,.001
WMS-LM2 23.54 (8.41) 6.77 (6.07) 11.70 (6.99) 14.9/,.001
WMS-LMFR (%) 19.11 (21.57) 26.36 (90.17
1) 18.34 (32.16) .1/.924
WMS-VR1 38.33 (2.10) 23.95 (7.31) 29.7 (9.41) 12.7/,.001
WMS-VR2 34.42 (6.34) 13.42 (10.75) 21.5 (13.52) 9.6/,.001
WMS-VRFR (%) 10.07 (17.14) 49.28 (34.14) 35.89 (36.89) 3.5/.042
Means are given with standard deviations in parentheses. AD: Alzheimer’s
disease, FTLD: frontotemporal lobar degeneration, CDR: Clinical Dementia
Rating Scale, GLM: General Linear Model, WMS: Wechsler Memory Scale, LM:
Logical Memory 1: immediate, 2: delayed, FR: forgetting rate), VR: Visual
Reproduction 1: immediate, 2: delayed, FR: forgetting rate). For further analyses
see text.
1The high standard deviation in this test measure was due to the fact that one
AD patient recalled more information in the delayed compared to the
immediate recall, although on an extremely low level of performance (one item
in the immediate and four items in the delayed recall, thus resulting in
a forgetting rate of 2300).
doi:10.1371/journal.pone.0055251.t001
Dissociating Memory Networks in Early AD and FTLD
PLOS ONE | www.plosone.org 2 February 2013 | Volume 8 | Issue 2 | e55251evaluation. Thus, these subjects had noticed normal, age-related
decreases in cognitive performance which concerned them.
Therefore, they presented at the clinic and asked for a screening
for dementia. Their CDR scores ranged between 0 and 0.5.
FDG-PET and MRI as well as the neuropsychological
assessment were conducted for diagnostic reasons within the
clinical assessment. Subjects were excluded if structural imaging
revealed lesions due to stroke, traumatic brain injury, brain tumor
or inflammatory diseases. Diagnoses were made prior to comput-
ing all subsequent analyses, i. e. the group differences as well as the
correlations between test measures and imaging parameters. As
can be seen from Table 1, CDR scores indicated early dementia
stage for both AD and FTLD. Furthermore, all three groups
differed significantly with respect to age (F=5.3; p,.01) and CDR
(F=16.2/p,.001), but neither with respect to years of education
(F,1) nor gender (x
2=.62; p=.73). We found differences between
each of the dementia groups versus the controls with respect to age
(AD vs. Controls: t(30)=2.9; p=.016; FTLD vs. Controls:
t(22)=2.9; p=.028) and CDR (AD vs. Controls: t(30)=5.2;
p,.001, FTLD vs. Controls: t(22)=4.7; p,.001). Therefore, age
was included as a covariate to control for a possible confounding
impact of age on the outcome measures. AD and FTLD patients
did not differ from one another with respect to age (t(28)=2.5;
p..99) and CDR (t(28)=2.2; p..99).
Ethics Statement
Written informed consent was obtained from subjects to analyse
their diagnostic data retrospectively. In cases in which the ability
to consent was already compromised as the disease had
progressed, consent was obtained by caregivers (family members).
The research protocol was approved by the ethics committee of
the University of Leipzig, and was in accordance with the latest
version of the Declaration of Helsinki.
Neuropsychological Assessment
Memory performance in the present study was assessed with
two subtests from the German version of the revised Wechsler
Memory Scale (WMS-R) [57]: In the subtest Logical Memory (LM),
two brief stories are read to the subject by the examiner. The
participant is asked to recall as many details as possible of each
story, both immediately following each presentation (Logical
Memory I, maximum score 50) and after a delay of approximately
30 minutes (Logical Memory II, maximum score 50). In the Visual
Reproduction (VR) subtest, subjects are asked to recall four briefly
presented abstract figures by drawing them from memory. As in
the LM subtest, the VR figures are to be recalled both immediately
after each presentation (Visual Reproduction I, maximum score
41) and after a 30 min delay (Visual Reproduction II, maximum
score 41). The WMS-R is widely used for the assessment of
memory deficits and has been investigated extensively [58]. In
meta-analyses, several WMS subtests have proven to dissociate AD
patients from normal controls, especially with respect to delayed
recall measures [59]. Furthermore, the Visual Reproduction subtest
might be useful to distinguish AD from FTLD patients [14]. In
addition to the original immediate and delayed recall measures of
each subtest, we computed forgetting rates (FR) as this measure
has been proposed to be of value in differentiating between AD
and FTLD patients [11,24]. Forgetting rates (FR) were computed
as individually normalized values according to the following
formula for LM and VR, respectively: FR=(immediate recall–
Figure 1. Group differences. Differences between AD patients and controls (upper part) as well as FTLD patients versus controls (lower part) in
brain glucose utilization (FDG-PET, red) and atrophy (MRI, blue). Areas of overlap are shown in violet. Only clusters are shown that exceeded
a significance threshold of p,0.001 uncorrected at voxel level and a cluster threshold of 2000 voxels. Left is left.
doi:10.1371/journal.pone.0055251.g001
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unavailable for some of the subjects: LM was available for 17 AD
patients, 10 FTLD patients and 13 control subjects and VR for all
19 AD patients, 10 FTLD patients and 12 control subjects. Three
subjects (1 AD, 1 FTLD and 1 control subject) underwent the LM
but not the VR subtest. For four subjects (3 AD and 1 FTLD), VR
was available but not the LM subtest. Differences between the
groups for each test (including FRs) were analyzed using general
linear models (GLMs) with a factor Group (Control vs. AD vs.
FTLD) and Age as a covariate. As age was not a significant
predictor for any of the tests, the post-hoc analyses were computed
only for the factor Group by using t-tests (p,.05) with a Bonferroni
adjustment (in case of significance).
Imaging Data Analysis
MRI data acquisition. For each subject, a high-resolution
T1-weighted MRI scan was obtained, consisting of 128 sagittal
slices adjusted to the AC (anterior commissure) - PC (posterior
commissure) line with a slice thickness of 1.5 mm and a pixel size
of 161m m
2. MRIs were performed on two different 3T scanners
(MedSpec 30/100, Bruker Biospin, Ettlingen Germany and
Magnetom Trio, Siemens, Erlangen, Germany) using two different
T1-weighted sequences (MDEFT or MP-RAGE with
TR=1300 ms, TI=650 ms, TE=3.93 ms or TE=10 ms; FOV
25625 cm
2; matrix =2566256 voxels). On the MedSpec
scanner, only the MDEFT sequence and on the Magnetom Trio
scanner, either MDEFT or MP-RAGE sequences were used. The
distribution of scanner types and sequences used to obtain the
MRI data was random across subjects and did not differ
significantly in its distribution, neither between the groups nor
between the scanner types nor between the sequences.
PET data acquisition. FDG-PET imaging was done either
a few weeks before or after the MRI scan. PET data were acquired
on a Siemens ECAT EXACT HR+ scanner (CTI/Siemens,
Knoxville, TN, USA) under a standard resting condition in a 2-
dimensional (2D) mode. Sixty-three slices were simultaneously
collected with an axial resolution of 5 mm full width at half
maximum (FWHM) and an in-plane resolution of 4.6 mm. After
correction for attenuation, scatter, decay and scanner-specific
dead-time, images were reconstructed by filtered back-projection
using a Hann-filter of 4.9 mm FWHM. The 63 transaxial slices
obtained had a matrix of 1286128 voxels with an edge length of
2.45 mm.
Preprocessing and imaging data analysis. Preprocessing
was performed using Statistical Parametric Mapping (SPM 5,
Wellcome Trust Centre for Neuroimaging) run with Matlab 7.7
(The MathWorks Inc., Natick, MA) applying the procedure
described in detail in ref [60]: Co-registration and interpolation of
MRI and FDG-PET images to a resolution of 16161m m
3,
partial volume effect correction of FDG-PET images using the
modified Mu ¨ller-Ga ¨rtner method [61], bias correction of MRI
data, spatial normalization to a study specific template using the
DARTEL approach (Diffeomorphic Anatomical Registration
Through Exponentiated Lie algebra, cf. [62]), modulation of
MRI data, masking of non gray matter voxels and smoothing
using a 12 mm FWHM kernel. Intensity values of FDG-PET scans
were normalized to the cerebellar values [63].
Whole brain correlation analyses were conducted between the
obtained gray matter volume or glucose metabolism maps and
Table 2. Differences in hypometabolism and atrophy between groups.
Regions Cluster size x y z T-value
FDG-PET
AD,Con bilateral inferior precuneus, bilateral dorsal posterior cingulate gyrus, left
inferior, middle and superior temporal gyrus, left inferior parietal lobule
63163 239 254 39 6.8
right inferior, middle and superior temporal gyrus, right inferior parietal lobule 16005 40 255 22 6.2
FTLD,Con left inferior, middle and superior frontal gyrus, left dorsal frontomedian
cortex, left superior anterior insula
34412 239 28 8 4.94
left inferior, middle and superior temporal gyrus, left inferior parietal lobule 21621 255 233 217 4.75
MRI
AD,Con right middle occipital gyrus 3495 30 280 19 6.28
right inferior and middle occipital gyrus, right posterior inferior and
middle temporal gyrus
4535 39 275 28 5.76
bilateral dorsal posterior cingulate cortex, bilateral inferior precuneus,
bilateral retrosplenial cortex
8822 1 245 29 5.61
left posterior superior, middle and inferior temporal gyrus, left inferior
parietal lobule/angular and supramarginal gyrus
17798 244 245 8 4.86
left posterior hippocampus, left thalamus 4376 218 235 21 4.83
left middle occipital gyrus 2347 229 281 14 4.34
left inferior frontal gyrus, left inferior frontal sulcus 2994 245 17 21 4.3
FTLD,Con left parahippocampal gyrus, left anterior hippocampus, left temporal pole, left
subcallosal area, left anterior and posterior insula, left anterior cingulate cortex,
left caudate head, left anterior putamen, left ventral striatum, left basal
forebrain, left middle and inferior temporal gyri, bilateral rectal gyrus,
bilateral inferior frontomedian cortex
35995 252 214 218 5.91
left posterior thalamus 2033 217 235 2 3.99
Statistical results for the comparisons between each dementia group and controls with respect to hypometabolism (FDG-PET) and atrophy (MRI). Cluster size is reported
in voxels, voxel size was 16161 mm.
doi:10.1371/journal.pone.0055251.t002
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between the groups, it was included as a covariate in all correlation
analyses. A significance threshold of p,.001 (uncorrected) at
voxel-level and a cluster extent threshold of 2000 voxels were used
in all analyses. The cluster threshold was used to exclude smaller
clusters from the analysis and thereby decrease the risk of false
positive errors. The high extent threshold results from the
interpolation of the imaging data to a 16161m m
3 resolution
and corresponds to about 70 voxels in the original FDG-PET
image which is in the range of commonly applied extent thresholds
for this type of data. Correlation analyses in FDG-PET and MRI
were performed for all six test scores (VR1, VR2, LM1, LM2,
VRFR, LMFR) for either AD patients and controls or FTLD
patients and controls, respectively. Additionally, to enable an
evaluation of both glucose utilization and brain volume in
dementia patients, group comparisons with respect to FDG-PET
and MRI were computed over all 43 subjects to investigate
differences between each group of dementia patients and control
subjects, respectively. For the group comparisons, age, gender and
total intracranial volume (only for MRI) were included as
covariates. Additionally, we performed conjunction analyses to
investigate similarities between observed imaging patterns corre-
lating with single WMS-R measurements in the groups including
either AD or FTLD patients.
Results
Neuropsychological Data
Table 1 depicts the test results for each patient group and the
controls. As the ANOVA results show, the three groups differed
significantly with respect to performance in LM1, LM2, VR1,
VR2 and VRFR, but not LMFR. There were significant group
differences between each of the dementia groups versus controls
for LM1 (AD vs. Controls: t(28)=27.8/p,.001, FTLD vs.
Controls: t(21)=26.8; p,.001), LM2 (AD vs. Controls:
t(28)=26.4; p,.001, FTLD vs. Controls: t(21)=23.6;
p=.001), VR1 (AD vs. Controls: t(29)=26.6; p,.001, FTLD
vs. Controls: t(20)=23.1; p=.017), and VR2 (AD vs. Controls:
t(29)=26.1; p,.001, FTLD vs. Controls: t(20)=23.0; p=.019).
However, AD and FTLD patients did not differ from one another
with respect to LM1 (t(25)=2.6; p..99), LM2 (t(25)=21.9;
p=.27), VR1 (t(27)=21.8; p=.13) and VR2 (t(26)=21.6;
Figure 2. Memory performance and hypometabolism. Correlations between hypometabolism (FDG-PET) and each memory measure for AD
patients and controls (blue) as well as FTLD patients and controls (red). LM: WMS Logical Memory, VR: WMS Visual Reproduction, 1: immediate recall, 2:
delayed recall, FR: Forgetting rate. Results are only reported for those memory measures for which significant correlations in any region were found.
Only clusters are shown that exceeded a significance threshold of p,0.001 uncorrected at voxel level and a cluster threshold of 2000 voxels. Left is
left.
doi:10.1371/journal.pone.0055251.g002
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between AD patients and control subjects (t(29)=3.7; p=.004),
but neither between FTLD patients and control subjects
(t(20)=2.2; p=.18) nor between AD and FTLD patients
(t(26)=.8; p..99). In sum, AD and FTLD patients performed
worse than controls, but both dementia groups did not differ from
one another. However, VRFR was significantly higher in AD, but
not in FTLD, compared to control subjects.
Imaging Results for Group Comparisons
Figure 1 displays hypometabolism (FDG-PET) and atrophy
(MRI) in AD and FTLD patients versus controls, respectively.
Statistical results can be found in Table 2. As can be seen from the
figure, AD patients showed a specific pattern of hypometabolism
(FDG-PET) especially in the parieto-mesial cortex (precuneus,
posterior cingulate), whereas hypometabolism in the FTLD group
was mainly found in the left fronto-median and fronto-lateral
cortex and in the insula. Hypometabolism in lateral temporal and
inferior parietal regions was seen in both groups in comparison to
controls. It was restricted to the left hemisphere in the FTLD
group, but occurred bilaterally in the AD patients.
Regional atrophy (MRI) was found in similar regions as
hypometabolism and additionally in subcortical structures. In
particular, gray matter (GM) loss in the (left) hippocampus and in
the thalamus was found in both groups. By contrast, only FTLD
patients exhibited atrophy in the insula, the basal ganglia and the
basal forebrain relative to control subjects.
Correlation Analyses
Figure 2 and Table 3 display the results of the correlation
analyses between metabolism and memory performance in each
dementia group and controls for each memory measure.
Correlations between atrophy and memory performance are
shown in Figure 3 and Table 4.
FDG-PET: AD patients and controls. Performance in the
immediate recall of verbal information (LM1) was correlated with
glucose metabolism in the bilateral parieto-mesial cortex (pre-
cuneus, retrosplenial and cingulate cortex) and in the lateral
parietal and temporal regions of both hemispheres, though much
more extensive in the left. Delayed verbal recall (LM2) was also
associated with bilateral parieto-mesial and left lateral temporal
glucose metabolism. Forgetting rates (LMFR) did not correlate
with glucose utilization in any region. Performance in immediate
visual recall (VR1) was correlated with glucose metabolism in left
parieto-mesial regions (cingulate gyrus, precuneus) and in
temporo-parietal regions in both hemispheres, with a focus in
the left hemisphere. Performance in the delayed recall of visual
information (VR2) was correlated with glucose metabolism in the
left inferior parietal lobe. We did not find any correlations between
glucose metabolism and visual forgetting rates (VRFR).
Figure 3. Memory performance and atrophy. Correlations between atrophy (MRI) and each memory measure for AD patients and controls
(blue) as well as FTLD patients and controls (red). Areas of overlap are shown in violet (in LM1 only). LM: WMS Logical Memory, VR: WMS Visual
Reproduction, 1: immediate recall, 2: delayed recall, FR: Forgetting rate. Results are only reported for those memory measures for which significant
correlations in any region were found. Only clusters are shown that exceeded a significance threshold of p,0.001 uncorrected at voxel level and
a cluster threshold of 2000 voxels. Left is left.
doi:10.1371/journal.pone.0055251.g003
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the immediate recall of verbal information (LM1) was correlated
with glucose metabolism especially in the left inferior frontal
cortex and in the left anterior insula. Neither delayed verbal
recall (LM2) nor verbal forgetting rates (LMFR) were correlated
with glucose metabolism in any region. Correlations between
the immediate recall of visual information (VR1) and glucose
metabolism were also accentuated in the frontal cortex, though
much more extensive compared to the verbal domain (LM1). In
addition to the left superior, middle and inferior frontal cortices,
correlations were also found in the frontomedian cortex
including the anterior cingulate gyrus. With respect to delayed
visual recall (VR2), we found that glucose metabolism and test
performance were again positively correlated in the left inferior
frontal cortex and in the insula, and additionally in the left
anterior hippocampus. Forgetting rates of visual information
were negatively correlated with glucose utilization in the lateral
inferior frontal cortices bilaterally and in the left insula, anterior
cingulate cortex, basal ganglia (esp. caudate), anterior hippo-
campus and basal forebrain.
MRI: AD patients and controls. Correlations between
performance in the immediate recall of verbal information
(LM1) and GM volume were found in bilateral parieto-mesial
areas (precuneus, cingulate gyrus) as well as in the left inferior
parietal and superior temporal cortex. We did not find any
correlations between the scores in the delayed verbal recall (LM2)
or verbal forgetting rates (LMFR), respectively, and gray matter
volumes in any region. Similarly, lower performance in the
immediate visual recall (VR1) was associated with lower GM
volume in parieto-mesial regions (precuneus, posterior cingulate).
Again, we did not find any correlations between the scores in
delayed verbal recall (LM2) or verbal forgetting rates (LMFR),
respectively, with GM volumes in any region.
Table 3. Memory performance and hypometabolism.
Subtest Regions Cluster size x y z T-value
AD and Controls
LM1 bilateral dorsal posterior cingulate gyrus,
bilateral precuneus, bilateral retrosplenial cortex
13338 25 239 30 7.68
left inferior parietal lobule, left middle and posterior superior/middle/
inferior temporal gyrus
43495 253 252 36 6.14
right posterior and middle superior temporal sulcus, right inferior, middle
and superior temporal gyrus
8210 48 235 2 5.01
right inferior parietal lobule 8166 27 249 42 4.34
LM2 bilateral dorsal posterior cingulate cortex 2477 24 238 26 5.46
left posterior superior and middle temporal gyrus 4703 268 244 22 4.32
LMFR n. s.
VR1 left inferior parietal lobule, left posterior middle and inferior temporal gyrus 23806 234 250 35 6.46
left dorsal posterior cingulate cortex, left precuneus 7156 216 248 36 5.88
right inferior parietal lobule, right temporo-parietal junction area 8970 37 251 42 4.89
VR2 left inferior parietal lobule/angular and supramarginal gyrus 6038 239 255 38 4.97
VRFR n. s.
FTLD and Controls
LM1 left posterior inferior frontal sulcus, left inferior frontal junction area 2384 237 7 36 4.5
left inferior frontal gyrus, left anterior superior insula 5097 237 10 10 4.47
left posterior superior frontal sulcus 2957 214 46 39 4.14
LM2 n. s.
LMFR n. s.
VR1 left inferior frontal gyrus (pars orbitalis, pars opercularis and pars
triangularis), left posterior middle and superior frontal gyrus
45383 245 13 41 6.66
bilateral anterior midcingulate cortex, bilateral paracingulate cortex, bilateral
dorsal frontomedian cortex, bilateral posterior superior frontal gyrus
10849 3 36 24 5.25
VR2 left inferior frontal gyrus (pars orbitalis and triangularis), left superior
anterior insula
7049 249 32 26 6.18
left anterior hippocampus, left inferior insula 3017 230 211 214 5.56
VRFR left inferior frontal gyrus (pars orbitalis and pars triangularis); left anterior
insula, left caudate head, left ventral striatum, left basal forebrain
10776 247 32 28 6.05
left inferior insula, left anterior hippocampus 3594 236 28 213 5.72
right inferior frontal gyrus (pars orbitalis) 2186 43 35 23 4.54
left pregenual anterior cingulate cortex 2128 212 33 23 4.37
Statistical results for the correlations between each memory measure and hypometabolism (FDG-PET) for AD patients and controls as well as FTLD patients and controls.
Cluster size is reported in voxels, voxel size was 16161 mm.
doi:10.1371/journal.pone.0055251.t003
Dissociating Memory Networks in Early AD and FTLD
PLOS ONE | www.plosone.org 7 February 2013 | Volume 8 | Issue 2 | e55251MRI: FTLD patients and controls. Deficits in immediate
verbal recall (LM1) were correlated with atrophy in the
precuneus bilaterally, the right inferior frontal cortex, the left
insula and the left dorsal frontomedian cortex. Further
correlations were found in the bilateral orbitofrontal cortices
as well as the anterior cingulate cortex. Performance in the
immediate recall of visual information (VR1) was correlated
with GM volume in the inferior frontal and the orbitofrontal
cortices bilaterally and in the left parahippocampal gyrus as well
as in the basal ganglia (caudate, putamen), thalamus and
subcallosal area bilaterally. Correlations between performance in
the delayed recall of visual information (VR2) and brain volume
were mainly found in bilateral frontal cortical (anterior
cingulate) and subcortical areas (basal ganglia, subcallosal area),
and in the right inferior occipital gyrus. Visual forgetting rates
(VRFR) were negatively associated with GM volume in a large
cluster comprising the left inferior frontal gyrus, the left insula,
the anterior cingulate cortices, basal forebrain and basal ganglia
bilaterally as well as in an area in the right occipital cortex.
Conjunction analysis. We found an overlap of atrophy
(MRI) with respect to the LM1 subtest between AD and control
subjects, and FTLD and control subjects, respectively, in the
bilateral posterior cingulate cortex and the left superior temporal
gyrus (851 voxels, corresponding to 13.8% of all voxels in AD and
Table 4. Memory performance and atrophy.
Subtest Regions Cluster size x y z T-value
AD and Controls
LM1 left supramarginal gyrus, left posterior superior temporal gyrus 2279 252 246 23 4.81
bilateral dorsal posterior cingulate cortex, bilateral inferior precuneus 3894 1 250 29 4.48
LM2 n. s.
LMFR n. s.
VR1 bilateral dorsal posterior cingulate cortex, bilateral inferior precuneus 4028 22 249 24 4.92
VR2 n. s.
VRFR n. s.
FTLD and Controls
LM1 left superior temporal sulcus, left superior and middle temporal gyrus 6207 250 225 22 6.43
right inferior frontal gyrus (pars orbitalis and pars triangularis), right
superior anterior insula
2470 42 32 5 5.68
bilateral inferior precuneus 2322 3 252 36 4.93
right posterior inferior temporal gyrus 2286 46 261 213 4.91
bilateral subgenual anterior cingulate cortex, bilateral ventromedial
frontal cortex
4102 212 1 23 4.74
left superior anterior insula 4625 233 9 4 4.72
left paracingulate gyrus, left dorsal anterior frontomedian cortex 3241 25 42 37 4.12
LM2 n. s.
LMFR n. s.
VR1 right inferior frontal gyrus (pars orbitalis and pars triangularis), right
anterior superior insula
5386 41 35 22 5.94
bilateral thalamus, left posterior parahippocampal gyrus 7496 18 227 7 5.68
bilateral subcallosal area, bilateral ventromedial frontal cortex, bilateral
caudate head, left dorsal putamen, right anterior putamen, right ventral
striatum, right basal forebrain, left anterior insula, left inferior frontal
cortex (pars orbitalis and pars triangularis)
19147 237 35 23 5.59
left temporo-parietal junction area 2026 247 255 22 5.4
left anterior dorsal frontomedian cortex, left paracingulate cortex,
left superior frontal gyrus
2965 211 48 24 4.35
VR2 right inferior occipital gyrus 2935 38 276 210 6.84
bilateral subcallosal area, bilateral subgenual anterior cingulate cortex, bilateral
caudate head, bilateral anterior putamen, bilateral ventral striatum,
bilateral basal forebrain
5078 232 6 210 4.18
VRFR right inferior occipital gyrus 3623 38 276 210 7.1
right lingual gyrus 2402 7 270 26 6.16
left anterior insula, left inferior frontal gyrus (pars orbitalis and triangularis),
left anterior putamen, bilateral ventral striatum, bilateral basal forebrain,
bilateral rectal gyrus, bilateral subgenual anterior cingulate cortex,
bilateral caudate head
18253 242 24 24 5.2
Statistical results for the correlations between each memory measure and atrophy (MRI) for AD patients and controls as well as FTLD patients and controls. Cluster size is
reported in voxels, voxel size was 16161 mm.
doi:10.1371/journal.pone.0055251.t004
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see overlapping regions in Figure 3/LM1). No further overlaps
were observed in any of the remaining analyses.
Discussion
In the present study, we investigated the neural correlates of
immediate and delayed verbal and visual memory in patients with
early AD and FTLD with respect to both PET hypometabolism
and MR brain atrophy. To our knowledge, this is the first study
that investigates both patient groups with respect to different
memory domains (verbal, visual, forgetting rates) and different
imaging markers (glucose metabolism, GM volume) in a whole-
brain approach.
Lesion Patterns in AD and FTLD
Group comparisons in FDG-PET and MRI between each of the
dementia groups and control subjects largely replicate previous
findings from the literature. Hippocampal atrophy in the AD
group compared to controls in connection with GM loss in medial
and lateral parietal regions is a common finding [34,35]. The
absence of hypometabolism in the hippocampus seems more
surprising as there are diverging findings in the literature on this
issue [64]. Regional hypometabolism might have disappeared in
our study, because we corrected FDG-PET data for partial volume
effects according to atrophy – a procedure that is uncommonly
applied in the literature. Whereas the finding of atrophy in fronto-
median and fronto-lateral cortices and in the basal ganglia in
FTLD is expected with respect to previous studies
[20,49,50,60,65,66], hippocampal atrophy seems puzzling at first
sight. However, there are a number of studies which report
volume reductions in the hippocampus in FTLD [18–22,50,51],
also in pathologically validated FTD [16]. In a very recent study,
hippocampal atrophy did not differ between AD and FTD patients
which lead the authors to the general conclusion that the extent of
hippocampal atrophy is not an efficient diagnostic marker in order
to distinguish AD from FTD [66]. This latter study further
confirms the view that memory may be more severely affected
than previously assumed in these patients.
Memory Performance in AD and FTLD
With respect to memory test performance, the two dementia
subgroups did not differ from each other, although both
performed significantly lower than controls in all test measures,
except for visual forgetting rates where FTLD patients did not
differ from controls. This latter finding may point to slight
differences between the groups, probably due to stronger
visuospatial problems interfering with visual memory in the AD,
but not the FTLD group [14,18].
Findings of considerable memory impairments in early stages of
FTLD have already been reported which raised the questioned
whether FTLD and AD patients can be clearly distinguished on
the basis of memory test performance (see Introduction). The
results of our study support these findings as both dementia groups
did not differ in their abilities to retrieve information that has been
encoded initially, since even forgetting rates did not differ between
the groups. However, our results do not allow deciding whether
the low forgetting rates in AD and FTLD are caused by the same
mechanisms or whether both groups might nevertheless differ in
their abilities to consolidate information as our study did not
include recognition trials [11,12,24].
Neural Correlates of Memory in AD and FTLD
Aside from small atrophy overlaps in the LM1 subtest
(immediate recall of verbal information) as revealed by a conjunc-
tion analysis, we found that similar decreases in memory
performance between the two dementia groups had completely
different underlying neural substrates: The parieto-mesial cortex
(precuneus, retrosplenial and posterior cingulate cortex) correlated
with memory performance (both verbal and visual) only when the
AD group was included. This finding corroborates studies which
highlight the role of these areas in the development of AD (see
Introduction) as well as in the context of memory functions, such
as the retrieval of (episodic) memories in both healthy control
subjects (see refs [67–68] for reviews) and in patients with memory
deficits such as AD patients [48] or patients with transient global
ischemia [69]. One anatomical explanation for this role might be
the high interconnectivity between the medial parietal lobe and
medial temporal structures [68,70]. In contrast, when the FTLD
group was included, memory performance was primarily associ-
ated with metabolism and GM volume in frontal cortical (esp.
lateral and medial frontal cortex) and subcortical structures (insula,
basal ganglia, anterior cingulate, and basal forebrain). These
results are in line with earlier findings that these regions are
primarily affected in FTLD, a result which was also confirmed in
our group comparisons. Especially the inferior frontal cortex has
been shown to play an important role in encoding and retrieving
information [71–73]. Our results suggest that further areas are
involved in FTLD which are crucial for memory functions such as
the anterior cingulate cortex [71], the basal ganglia [74], and the
basal forebrain [75,76] which can all lead to severe amnesia in the
case of damage. Thus, although lesion patterns differed between
AD and FTLD, structures crucial for memory functions seemed to
be affected in both diseases.
Limitations of the Study
Finally, there are some limitations of our study. First of all, our
diagnostic classification was purely based on clinical criteria.
Further studies are needed to dissociate memory networks in
FTLD subtypes including histopathological validation.
Secondly, the small sample sizes (especially in the FTLD group),
principally limit a generalization of the results to the different
disease populations. Furthermore, the small sample sizes do not
allow dissociating possible differences in the memory related
networks between the FTLD subgroups (FTD, SD, mixed type).
Such differences as well as differences in memory performance
might be expected according to the literature (see Introduction).
Assigning all these patients to one group (which was not possible
otherwise due to the small number of subjects) might have lead to
the high variability thereby obscuring possible differences between
the FTLD and the AD group.
A reason why we did not observe differences between AD and
FTLD patients in any of the neuropsychological tests might be
a lack of power in our study resulting from the small sample sizes.
In fact, estimations of effect sizes for the differences in
neuropsychological test performance for both groups of patients
indicated small to medium sized effects for all of the neuropsy-
chological tests (between r=.06 to r=.36).
Another potential source of limitation for the interpretation of
differential spatial networks showing a correlation with neuropsy-
chological performance might be a lack of power in one of the
conditions. However, we do not think that the observed distinction
in networks can be explained by a lack of power, for the following
reasons: First of all, a lack of power in one of the conditions (either
correlations of imaging data with memory scores only in AD and
controls or only in FTLD and controls) would rather result in the
Dissociating Memory Networks in Early AD and FTLD
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condition. In contrast, what we found were two distinct networks
showing similarly significant correlations with the neuropsycholo-
gical performance in both analyses. Secondly, we found even
slightly higher t-values in some of the correlation analyses with the
smaller number of subjects (FTLD and controls) which is the
opposite of what one would expect if the difference in results would
be attributable to a lack of power.
In addition, we cannot completely rule out the objection that
subjects with cognitive complaints were not ideal controls.
Including these subjects as controls might have underestimated
the deficits in the two dementia groups. Nevertheless, we think that
it was justified to include them as a comparison group for the
following reasons: In the examination, it became clear that these
subjects experienced an age-related -though not abnormal
according to our assessment- cognitive decline which concerned
them (e. g. that they were not as fast at work anymore or could not
memorize as many details compared to earlier ages). None of them
had a CDR score greater than 0.5 which is also found frequently
in random samples from the normal population. An earlier study
e. g. reported that 23% of the subjects in a random sample had
a CDR of 0.5 [77], although the mean age in these subjects was
higher than in ours. Certainly, one general limitation of studies
such as ours is that, for ethical reasons, invasive techniques such as
PET should not be applied without clinical justification.
Furthermore, we do not claim that early AD and FTLD patients
have a completely identical profile with respect to their memory
abilities. Our results only show that widely used neuropsycholo-
gical test measures of immediate and delayed recall may not
differentiate between the groups, even if additional parameters
such as forgetting rates are applied. We cannot exclude that other
test parameters (such as a recognition paradigm), experimental
procedures (e. g. on source memory) or more naturalistic tasks
(such as incidental encoding) may reveal differences (see ref [27]
for a review).
Last but not least: We have used the term ‘‘network’’ very
generally. In fact, we have only identified patterns of brain areas in
which the extent of damage is correlated with a task performance.
However, we have used a rather ‘‘static’’ methodological approach
(atrophy and metabolism at rest) which did not allow disentangling
the dynamic interplay of these areas while a specific function is
carried out in a lesioned brain. This would be an aim for further
studies using methods such as DTI, task-related fMRI or resting
state connectivity [78–80].
Conclusion
We have shown that memory test performance may not
differentiate between early AD and FTLD, but that the underlying
memory networks can nevertheless be clearly dissociated with
respect to both hypometabolism and atrophy. Furthermore, this
dissociation does not depend on a priori hypotheses with respect to
specific brain areas, but can also be shown in a data-driven, whole
brain approach. This finding contributes to a more profound
understanding of how memory processes are connected to the
degeneration of the underlying neural networks.
With respect to clinical practice, even severe memory problems
should not automatically exclude the diagnosis of FTLD as this
might lead to misclassifications [26]. With respect to the
classification of clinical dementia syndromes, our data suggest
that respective algorithms should include a diversity of clinical as
well as imaging parameters in order to reveal the crucial
differences.
More generally, our data speak in favour of a view according to
which functions are not strictly ‘‘localized’’ in the brain but are
carried out by distributed networks. This view leads to interesting
predictions for how the brain deals with lesions [79]. Neurode-
generative dementias are ‘‘paradigmatic’’ for this network view as
these diseases crucially involve lesions of central nexuses (‘‘hubs’’)
[80]. This leads to a loss of connectivity to a degree which cannot
be compensated anymore by the rest of the brain and therefore
leads to the far-reaching disabilities in dementing illnesses.
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